APA (7th ed.) Citation

Liu, P., Chen, Y., Chen, W., Ho, C., & Lee, C. (2026). Acquired ROS1 Intragenic Rearrangements as a Resistance Mechanism in EGFR -Mutant Non-Small Cell Lung Cancer: A Case Series. Current Oncology, 33(6), 311. https://doi.org/10.3390/curroncol33060311

Chicago Style (17th ed.) Citation

Liu, Po-Tsen, Yi-Lin Chen, Wan-Li Chen, Chung-Liang Ho, and Chun-Hui Lee. "Acquired ROS1 Intragenic Rearrangements as a Resistance Mechanism in EGFR -Mutant Non-Small Cell Lung Cancer: A Case Series." Current Oncology 33, no. 6 (2026): 311. https://doi.org/10.3390/curroncol33060311.

MLA (9th ed.) Citation

Liu, Po-Tsen, et al. "Acquired ROS1 Intragenic Rearrangements as a Resistance Mechanism in EGFR -Mutant Non-Small Cell Lung Cancer: A Case Series." Current Oncology, vol. 33, no. 6, 2026, p. 311, https://doi.org/10.3390/curroncol33060311.